Wockhardt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
1,174.60
-12.05 (-1.02%)
BSENSE

Mar 20

BSE+NSE Vol: 4.35 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Sai Life
Emcure Pharma
Natco Pharma
Gland Pharma
Pfizer
ERIS Lifescience
Astrazeneca Phar
Piramal Pharma
OneSource Speci.
Wockhardt

Why is Wockhardt Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.74%
  • Poor long term growth as Net Sales has grown by an annual rate of 2.66% over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 13.08 times
2
With ROCE of 3.7, it has a Expensive valuation with a 3.4 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -20.04%, its profits have risen by 167.1% ; the PEG ratio of the company is 0.9
3
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.56% over the previous quarter and collectively hold 17.56% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -20.04% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Wockhardt for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Wockhardt
-20.04%
-0.39
51.76%
Sensex
-2.38%
-0.19
12.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.66%
EBIT Growth (5y)
25.96%
EBIT to Interest (avg)
0.06
Debt to EBITDA (avg)
17.98
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
0.49
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
18.04%
Institutional Holding
17.56%
ROCE (avg)
-1.18%
ROE (avg)
0.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
149
Industry P/E
31
Price to Book Value
4.18
EV to EBIT
78.08
EV to EBITDA
41.98
EV to Capital Employed
3.38
EV to Sales
6.54
PEG Ratio
0.89
Dividend Yield
NA
ROCE (Latest)
3.69%
ROE (Latest)
1.62%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
PBT LESS OI(Q)

At Rs 52.00 cr has Grown at 1385.7% (vs previous 4Q average

PAT(Q)

At Rs 68.10 cr has Grown at 268.1% (vs previous 4Q average

DEBTORS TURNOVER RATIO(HY)

Highest at 5.57 times

NET SALES(Q)

Highest at Rs 888.00 cr

-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Wockhardt

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 52.00 cr has Grown at 1385.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 3.50 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 68.10 cr has Grown at 268.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 18.50 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 888.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 5.57 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Wockhardt

Non Operating Income - Quarterly
Highest at Rs 25.00 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income